Arcturus Therapeutics Holdings Inc (ARCT)

04:03 AM

mRNA drug maker Arcturus hits Jefferies 2026 healthcare stage in New York - Stock Titan

04:03 AM

04:01 AM

Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference - Yahoo Finance

04:01 AM

May 19, 2026

William Blair Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating - Moomoo

May 19, 2026

May 18, 2026

How (ARCT) Movements Inform Risk Allocation Models - Stock Traders Daily

May 18, 2026

May 18, 2026

Arcturus Therapeutics unveils OTC deficiency research at SIMD 2026 Annual Meeting - Traders Union

May 18, 2026

May 17, 2026

Arcturus Therapeutics Holdings Inc (NQ: ARCT - FinancialContent

May 17, 2026

May 13, 2026

HC Wainwright & Co. Maintains Arcturus Therapeutics Holdings (ARCT) Neutral Recommendation - MSN

May 13, 2026

May 13, 2026

ARCTURUS THERAPEUTICS HOLDINGS INC UPSWING STARTED | ARCT STOCK NEWS (VWpPDIK5Ud) - fathomjournal.org

May 13, 2026

May 13, 2026

H.C. Wainwright Maintains Arcturus Therapeutics(ARCT.US) With Hold Rating, Maintains Target Price $9 - Moomoo

May 13, 2026

May 12, 2026

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Consensus Forecasts Have Become A Little Darker Since Its Latest Report - simplywall.st

May 12, 2026

May 11, 2026

Guggenheim Maintains Arcturus Therapeutics(ARCT.US) With Hold Rating - Moomoo

May 11, 2026

May 09, 2026

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

May 09, 2026

May 09, 2026

MSN Money - MSN

May 09, 2026

May 08, 2026

Roth MKM Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $20 - Moomoo

May 08, 2026

May 08, 2026

Arcturus Therapeutics Holdings Inc. Q1 2026 Earnings Call Summary - Yahoo Finance

May 08, 2026

May 08, 2026

Arcturus Therapeutics (ARCT) Reports Progress in Q1 2026 Earnings Call - GuruFocus

May 08, 2026

May 08, 2026

Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress - BioSpace

May 08, 2026

May 08, 2026

CCORF Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $21 - Moomoo

May 08, 2026

May 07, 2026

Earnings call transcript: Arcturus Therapeutics Q1 2026: EPS Beat, Revenue Decline - Investing.com

May 07, 2026

May 07, 2026

Trading Systems Reacting to (ARCT) Volatility - Stock Traders Daily

May 07, 2026

May 07, 2026

ARCT: Advanced rare disease pipeline, reduced expenses, and strong cash position support 2026 milestones - TradingView

May 07, 2026

May 07, 2026

ARCT: Achieved key clinical milestones in rare disease mRNA programs with strong financial runway - TradingView

May 07, 2026

May 07, 2026

Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance

May 07, 2026

May 07, 2026

Biotechnology company Arcturus Therapeutics Holdings Inc. recently announced through a filing with the U.S. Securities and Exchange Commission (SEC) that Mr. Dennis Mulroy has been officially appointed as the company's Chief Financial Officer (CFO), eff - Bitget

May 07, 2026

May 07, 2026

Arcturus Therapeutics Reports Q1 Results, Advances Rare Disease Pipeline - TipRanks

May 07, 2026

May 07, 2026

Arcturus Therapeutics Q1 Earnings Call Highlights - Yahoo Finance

May 07, 2026

May 07, 2026

12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga

May 07, 2026

May 07, 2026

Arcturus Therapeutics Holdings (NASDAQ:ARCT) Q1 2026 Results: Revenue Miss Weighs on Sentiment as Pipeline Advances - ChartMill

May 07, 2026

May 07, 2026

Arcturus Therapeutics: Q1 Earnings Snapshot - marketscreener.com

May 07, 2026

May 07, 2026

Arcturus Therapeutics (ARCT) CFO granted 100,000 stock options - Stock Titan

May 07, 2026

May 07, 2026

[Form 3] Arcturus Therapeutics Holdings Inc. Initial Statement of Beneficial Ownership - Stock Titan

May 07, 2026

May 07, 2026

Q1 2026 Arcturus Therapeutics Holdings Inc Earnings Call Transcript - GuruFocus

May 07, 2026

May 07, 2026

Arcturus Therapeutics (NASDAQ: ARCT) Q1 2026 hit by 93% revenue drop - Stock Titan

May 07, 2026

May 07, 2026

Arcturus Therapeutics Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 07, 2026

May 07, 2026

Revenue plunge and leadership change at Arcturus (NASDAQ: ARCT) - Stock Titan

May 07, 2026

May 07, 2026

ARK/ Cathie Wood report 2.95M shares in Arcturus (ARCT) - Stock Titan

May 07, 2026

May 06, 2026

Arcturus Therapeutics Holdings Inc (ARCT) Q1 2026 Earnings Repor - GuruFocus

May 06, 2026

May 06, 2026

Arcturus Therapeutics Holdings Inc at Barclays Global Healthcare Conference Transcript - GuruFocus

May 06, 2026

May 01, 2026

Arcturus Therapeutics (ARCT) Projected to Post Earnings on Thursday - MarketBeat

May 01, 2026

Apr 28, 2026

Arcturus Therapeutics (NASDAQ:ARCT) Shares Cross Below 200 Day Moving AverageTime to Sell? - MarketBeat

Apr 28, 2026

Apr 27, 2026

Arcturus Therapeutics Holdings (ARCT) price target decreased by 27.17% to 25.78 - MSN

Apr 27, 2026

Apr 27, 2026

Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May - PharmiWeb.com

Apr 27, 2026

Apr 27, 2026

Press Release: Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026 - 富途牛牛

Apr 27, 2026

Apr 27, 2026

Arcturus plans after-hours results and a 4:30 p.m. ET call May 7 - Stock Titan

Apr 27, 2026

Apr 27, 2026

Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026 - marketscreener.com

Apr 27, 2026

Apr 26, 2026

How Arcturus Therapeutics Holdings Inc. (ARCT) Affects Rotational Strategy Timing - Stock Traders Daily

Apr 26, 2026

Apr 25, 2026

ARCT Price Today: Arcturus Therapeutics Holdings Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange

Apr 25, 2026

Apr 24, 2026

Arcturus (NASDAQ: ARCT) schedules 2026 virtual meeting on pay, board and auditor - Stock Titan

Apr 24, 2026

Apr 24, 2026

Vertex Pharmaceuticals Inc. stock outperforms competitors despite losses on the day - MarketWatch

Apr 24, 2026